ArticleBMC neurology2017

Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study.

Meritxell Sabidó-Espin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.